These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2880603)

  • 21. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
    Svendsen TL; Trap-Jensen J; Carlsen JE; McNair A
    Am Heart J; 1985 May; 109(5 Pt 2):1145-50. PubMed ID: 2859778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
    Harry JD
    Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
    Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
    Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
    Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of atenolol in patients with coronary artery disease.
    Robinson C; Jackson G; Fisk C; Jewitt D
    Br Heart J; 1978 Jan; 40(1):22-8. PubMed ID: 341928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
    Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
    J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.
    Marlin GE; Kumana CR; Kaye CM; Smith DM; Turner P
    Br J Clin Pharmacol; 1975 Apr; 2(2):151-7. PubMed ID: 1234497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of beta 1- versus beta 2-adrenoceptor blockade on left ventricular function in humans.
    Vanhees L; Aubert A; Fagard R; Hespel P; Amery A
    J Cardiovasc Pharmacol; 1986; 8(5):1086-91. PubMed ID: 2429084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.
    Venneker EH; Remme WJ; van Hoogenhuyze DC; Krauss XH; Bartels GL; Kruijssen DA; Storm CJ; van Schelven D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):211-9. PubMed ID: 7918133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.
    Hanratty CG; Silke B; Riddell JG
    Br J Clin Pharmacol; 1999 Feb; 47(2):157-66. PubMed ID: 10190650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic sympathomimetic activity and coronary blood flow.
    Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1982; 13(Suppl 2):175S-180S. PubMed ID: 6125167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisoprolol: a new beta-adrenoceptor blocking drug.
    Prichard BN
    Eur Heart J; 1987 Dec; 8 Suppl M():121-9. PubMed ID: 2897295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.